Coronary artery bypass grafting versus percutaneous coronary intervention: a comparison of efficacy in patients with complex coronary artery disease.

Authors

  • Gabriella Corrêa Leite Unicesumar, Maringá- PR
  • Bianca de Oliveira Bisognin Unicesumar, Maringá-PR
  • Giuliana Silva Mossini Pinheiro Unicesumar, Maringá-PR
  • Isabela Dala Pedra Cadan Unicesumar, Maringá-PR
  • Mirella Cristina Mazuqueli Marques Universidade de Marília, Marília- SP
  • Rafael Felipe Moro Unicesumar, Maringá-PR
  • Marcus Roberto Andreucci Unicesumar, Maringá-PR

DOI:

https://doi.org/10.36557/2674-8169.2026v8n3p1457-1471

Keywords:

Surgical Procedures, Coronary Artery Bypass Grafting, Percutaneous Coronary Intervention (PCI), Quality of Life, Intraoperative Complications, Hospitalization, Cost-Benefit Analysis

Abstract

Introduction: Coronary artery disease (CAD) is one of the leading causes of death worldwide, with the most severe presentation being three-vessel disease and involvement of the left main coronary artery. In these conditions, myocardial revascularization is performed through coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI). Objectives: To compare the proposed intervention techniques according to adverse events, complications, the need for new interventions, and impact on quality of life to determine the most effective technique. Methodology: This study is a systematic review with a qualitative and exploratory approach. The research was conducted in the PubMed database, and the final articles were selected by two independent reviewers based on inclusion criteria involving clinical trials, adult patients diagnosed with complex coronary artery disease who required CABG or PCI interventions, published between 2015 and 2025. Conclusion: The comparison between both surgical procedures demonstrated the presence of distinct benefits that make the choice dependent on individual patient factors such as age, associated comorbidities, complexity of coronary lesions, and life expectancy. Myocardial revascularization surgery showed a reduction in complications due to protection against major cardiovascular events, less need for reinterventions, and, consequently, better long-term clinical and economic performance, especially in patients with complications. Meanwhile, PCI was advantageous in terms of periprocedural complications (stroke, infections, and atrial fibrillation), shorter hospital stays, and faster return to daily activities. Thus, both procedures proved to be effective and valid according to the patient's needs.

Downloads

Download data is not yet available.

References

BEN-YEHUDA, O. et al. Impact of large periprocedural myocardial infarction on mortality after percutaneous coronary intervention and coronary artery bypass grafting for left main disease: an analysis from the EXCEL trial. European Heart Journal, v. 40, n. 24, p. 1930-1941, 2019. DOI: https://doi.org/10.1093/eurheartj/ehz113

CHANG, M. et al. Coronary artery bypass grafting versus drug-eluting stents implantation for previous myocardial infarction. American Journal of Cardiology, v. 118, n. 1, p. 17-22, 2016. DOI: https://doi.org/10.1016/j.amjcard.2016.04.009

DAVIERWALA, P. M. et al. Single or multiple arterial bypass graft surgery vs. percutaneous coronary intervention in patients with three-vessel or left main coronary artery disease. European Heart Journal, v. 43, n. 13, p. 1334-1344, 2022. DOI: https://doi.org/10.1093/eurheartj/ehab537

FEARON, W. F. et al. Outcomes after fractional flow reserve-guided percutaneous coronary intervention versus coronary artery bypass grafting (FAME 3): 5-year follow-up of a multicentre, open-label, randomised trial. The Lancet, v. 405, n. 10488, p. 1481-1490, 2025. DOI: https://doi.org/10.1016/S0140-6736(25)00505-7

GIUSTINO, G. et al. Major bleeding and mortality after revascularization of left main disease. Journal of the American College of Cardiology, v. 84, n. 24, p. 2335-2346, 2024. DOI: https://doi.org/10.1016/j.jacc.2024.07.065

JAIN, S. S. et al. Impact of periprocedural adverse events after PCI and CABG on 5-year mortality: the EXCEL trial. JACC: Cardiovascular Interventions, v. 16, n. 3, p. 303-313, 2023. DOI: https://doi.org/10.1016/j.jcin.2022.10.011

KOSMIDOU, I. et al. New-onset atrial fibrillation after PCI or CABG for left main disease: the EXCEL trial. Journal of the American College of Cardiology, v. 71, n. 7, p. 739-748, 2018. DOI: https://doi.org/10.1016/j.jacc.2017.12.012

KOSMIDOU, I. et al. Incidence, predictors, and impact of hospital readmission after revascularization for left main coronary disease. Journal of the American College of Cardiology, v. 83, n. 11, p. 1073-1081, 2024. DOI: https://doi.org/10.1016/j.jacc.2024.01.012

MÄKIKALLIO, T. et al. Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial. The Lancet, v. 388, n. 10061, p. 2743-2752, 2016. DOI: https://doi.org/10.1016/S0140-6736(16)32052-9

MYRMEL, T.; LAMØY BJØRU, A.; CAPPELEN ENDRESEN, P. Survival after PCI or CABG for left main stem coronary stenosis: a single institution registry from the NOBLE study period. Scandinavian Cardiovascular Journal, v. 57, n. 1, 2023. DOI: https://doi.org/10.1080/14017431.2023.2197184

OSNABRUGGE, R. L. et al. Cost-effectiveness of percutaneous coronary intervention versus bypass surgery from a Dutch perspective. Heart, v. 101, n. 24, p. 1980-1988, 2015. DOI: https://doi.org/10.1136/heartjnl-2015-307578

PARK, D. W. et al. Ten-year outcomes after drug-eluting stents versus coronary artery bypass grafting for left main coronary disease: extended follow-up of the PRECOMBAT trial. Circulation, v. 141, n. 18, p. 1437-1446, 2020. DOI: https://doi.org/10.1161/CIRCULATIONAHA.120.046039

SHLOFMITZ, E. et al. Left main coronary artery disease revascularization according to the SYNTAX score. Circulation: Cardiovascular Interventions, v. 12, n. 9, 2019. DOI: https://doi.org/10.1161/CIRCINTERVENTIONS.118.008007

STONE, G. W. et al. Five-year outcomes after PCI or CABG for left main coronary disease. New England Journal of Medicine, v. 381, n. 19, p. 1820-1830, 2019. DOI: https://doi.org/10.1056/NEJMoa1909406

ZIMMERMANN, F. M. et al. Fractional flow reserve-guided PCI or coronary bypass surgery for 3-vessel coronary artery disease: 3-year follow-up of the FAME 3 trial. Circulation, v. 148, n. 12, p. 950-958, 2023. DOI: https://doi.org/10.1161/CIRCULATIONAHA.123.065770

Published

2026-03-22

How to Cite

Leite, G. C., de Oliveira Bisognin, B., Silva Mossini Pinheiro, G., Dala Pedra Cadan, I., Cristina Mazuqueli Marques, M., Felipe Moro, R., & Roberto Andreucci, M. (2026). Coronary artery bypass grafting versus percutaneous coronary intervention: a comparison of efficacy in patients with complex coronary artery disease. Brazilian Journal of Implantology and Health Sciences, 8(3), 1457–1471. https://doi.org/10.36557/2674-8169.2026v8n3p1457-1471